HERANTIS PHARMA OYJ |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.495 EUR | +1.36% |
|
+5.28% | -5.08% |
| Mar. 06 | Herantis Pharma Oyj Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 06 | Transcript : Herantis Pharma Oyj, 2023 Earnings Call, Mar 06, 2024 |
Quotes 5-day view
Delayed Quote Nasdaq Helsinki| 2024-04-18 | 2024-04-19 | 2024-04-22 | 2024-04-23 | 2024-04-24 | |
|---|---|---|---|---|---|
| Last | 1.45 € | 1.435 € | 1.45 € | 1.475 € | 1.495 € |
| Volume | 39 130 | 25 152 | 34 386 | 32 976 | 27 218 |
| Change | +2.11% | -1.03% | +1.05% | +1.72% | +1.36% |
| Opening | 1.45 | 1.48 | 1.45 | 1.47 | 1.46 |
| High | 1.49 | 1.50 | 1.52 | 1.53 | 1.5 |
| Low | 1.45 | 1.42 | 1.45 | 1.45 | 1.46 |
Performance
| 1 day | +1.36% | ||
| 1 week | +5.28% | ||
| Current month | +6.41% | ||
| 1 month | +4.55% | ||
| 6 months | -2.92% | ||
| Current year | -5.08% | ||
| 1 year | -32.05% | ||
| 3 years | -41.60% | ||
| 5 years | -74.22% |
Volumes
marketsDaily volume
27 218
Estimated daily volume
50 735
Avg. Volume 20 sessions
15 354
Daily volume ratio
3.30
Avg. Volume 20 sessions
22 954.23
Avg. Volume 20 sessions USD
24 524.53
Record volume 1
419 989
Record volume 2
252 667
Record volume 3
233 361
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (EUR)
29 780 681
Capitalization (USD)
31 817 977
Net sales (EUR)
0
Net sales (USD)
0
Number of employees
10
Sales / Employee (EUR)
0
Sales / Employee (USD)
0
Free-Float
69.93 %
Free-Float capitalization (EUR)
20 826 396
Free-Float capitalization (USD)
22 251 129
Average Daily Capital Traded
0.08%
Highs and lows
1 week
1.42
1.53
1 month
1.361.53
Current year
1.171.60
1 year
1.172.20
3 years
1.173.59
5 years
1.1710.80
10 years
0.7711.00
Indicators
Moving average 5 days
1.45
Moving average 20 days
1.43
Moving average 50 days
1.40
Moving average 100 days
1.47
Price spread / (MMA5)
-3.28%
Price spread / (MMA20)
-4.45%
Price spread / (MMA50)
-6.17%
Price spread / (MMA100)
-1.34%
STIM
RSI 9 days
56.89
RSI 14 days
54.48
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +1.36% | +5.28% | -5.08% | -32.05% | 31.82M | ||
| +1.25% | +2.72% | -0.49% | +22.30% | 105B | ||
| +0.80% | +1.47% | +3.31% | +13.31% | 97.5B | ||
| +1.52% | +4.26% | +3.20% | +0.51% | 22.19B | ||
| +0.55% | +2.49% | -16.16% | -25.19% | 21.33B | ||
| -0.10% | -0.15% | -7.01% | -28.53% | 18.68B | ||
| +1.26% | +3.50% | -41.41% | -44.21% | 16.6B | ||
| +6.25% | +3.78% | -22.87% | -46.17% | 14.52B | ||
| +4.81% | +5.34% | +6.32% | +34.48% | 14.09B | ||
| +0.14% | -0.14% | +21.46% | -8.49% | 10.99B | ||
| +0.83% | -5.33% | -21.14% | -31.92% | 8.63B | ||
| +1.92% | +2.35% | +14.99% | +78.96% | 8.27B | ||
| -0.24% | +1.67% | -0.94% | +54.87% | 7.62B | ||
| +1.69% | -4.44% | +248.90% | +206.13% | 7.16B | ||
| -1.09% | -4.97% | -21.46% | +71.02% | 6.87B | ||
| -0.62% | -3.15% | -56.42% | -74.12% | 6.9B | ||
| Average | +0.95% | +0.31% | +6.58% | +11.93% | ||
| Weighted average by Cap. | -0.20% | +1.26% | +0.96% | +10.40% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
def6fbfa5d132.zNO4A6-TyFMSI4iWo02OXtcRayw51Jf80RvejLVdA3k.vuPRcefX_gBfQOfM6SHRbp5SCkhTotuFnnW3ztE-ZzS_6o52xPufIWFnzQ
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 07:14:42 am | 1.495 | 10 | 27,218 |
| 07:09:18 am | 1.5 | 2,230 | 27,208 |
| 07:09:18 am | 1.5 | 300 | 24,978 |
| 07:09:18 am | 1.495 | 670 | 24,678 |
| 06:59:50 am | 1.475 | 500 | 24,008 |
| 06:58:56 am | 1.475 | 86 | 23,508 |
| 06:50:02 am | 1.495 | 600 | 23,422 |
| 06:17:56 am | 1.5 | 414 | 22,822 |
| 06:17:56 am | 1.5 | 800 | 22,408 |
| 06:17:56 am | 1.5 | 386 | 21,608 |
Monthly variations
Annual change
| 2024 | -6.35% | ||
| 2023 | -4.55% | ||
| 2022 | -31.25% | ||
| 2021 | -42.17% | ||
| 2020 | -46.45% | ||
| 2019 | +40.91% | ||
| 2018 | +2.23% | ||
| 2017 | +88.77% | ||
| 2016 | +227.59% | ||
| 2015 | -87.39% | ||
| 2014 | -34.84% |
- Stock Market
- Equities
- HRTIS Stock
- Quotes Herantis Pharma Oyj
